Letters Multidisciplinary cancer teams

Crucial for population health

BMJ 2010; 340 doi: http://dx.doi.org/10.1136/bmj.c2125 (Published 20 April 2010) Cite this as: BMJ 2010;340:c2125
  1. Fiona Day, consultant in public health1,
  2. Colin Pollock,
  3. Caroline Brook,
  4. Alex Albus
  1. 1NHS Yorkshire and the Humber
  1. fiona.day{at}yorkshireandhumber.nhs.uk

    Although formal evidence on the cost benefits of clinical decision making by multidisciplinary teams in cancer may be lacking,1 the Cancer Reform Strategy identifies such team meetings as important for collecting and validating clinical cancer data, particularly comorbidities, performance status, and …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe